Differential effects of black raspberry and strawberry extracts on BaPDE-induced activation of transcription factors and their target genes

Molecular Carcinogenesis

Volumn 47, Issue 4, 2008, Pages 286-294

  Li, Jingxia ^a   Zhang, Dongyun ^a   Stoner, Gary D ^b   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

BaPDE; Berry; Chemoprevention; Gene expression; Transcription factors

Indexed keywords

BENZO[A]PYRENE; BENZO[A]PYRENE 4,5 OXIDE; BLACK RASPBERRY EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; STRAWBERRY EXTRACT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; ANTINEOPLASTIC AGENT; BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; CARCINOGEN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FREEZE DRYING; FRUIT (STRUCTURE); HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RASPBERRY; SIGNAL TRANSDUCTION; STRAWBERRY; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; FRUIT; GENE EXPRESSION REGULATION; HAMSTER; METABOLISM; PHYSIOLOGY;

FRAGARIA X ANANASSA; MESOCRICETUS AURATUS; RUBUS OCCIDENTALIS;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CELL LINE; CRICETINAE; FRAGARIA; FRUIT; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; NF-KAPPA B; PLANT EXTRACTS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 41449118918     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20377     Document Type: Article

References (38)

1. Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med 2004;50:145-149.
2. Heggie SJ, Wiseman MJ, Cannon GJ, et al. Defining the state of knowledge with respect to food, nutrition, physical activity, and the prevention of cancer. J Nutr 2003; 3837S-3842.
3. Genkinger JM, Platz EA, Hoffman SC, Comstock GW, Helzlsouer KJ. Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington county, Maryland. Am J Epidemiol 2004;160:1223-1233.
4. Xue H, Aziz RM, Sun N, et al. Inhibition of cellular transformation by berry extracts. Carcinogenesis 2001;22:351-356.
5. Kresty LA, Morse MA, Morgan C, et al. Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 2001;61:6112-6119.
6. Cooke D, Steward WP, Gescher AJ, Marczylo T. Anthocyans from fruits and vegetables - Does bright colour signal cancer chemopreventive activity? Eur J Cancer 2005;41:1931-1940.
7. Hope Smith S, Tate PL, Huang G, et al. Antimutagenic activity of berry extracts. J Med Food 2004;7:450-455.
8. Wedge D, Meepagala K, Magee J, Smith S, Huang G, Larcom L. Anticarcinogenic activity of strawberry, blueberry, and raspberry extracts to breast and cervical cancer cells. J Med Food 2001;4:49-51.
9. Bagchi D, Sen C, Bagchi M, Atalay M. Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc) 2004;69:75-80.
10. Sashwati R, Savita K, Helaine MA, et al. Anti-angiogenic property of edible berries. Free Radic Res 2002;36:1023-1032.
11. Carlton PS, Kresty LA, Siglin JC, et al. Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis 2001;22:441-446.
12. Huang C, Huang Y, Li J, et al. Inhibition of Benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor {kappa}B by black raspberry extracts. Cancer Res 2002;62:6857-6863.
13. Huang C, Li J, Song L, et al. Black raspberry extracts inhibit benzo(a)pyrene diol-epoxide-induced activator protein 1 activation and VEGF transcription by targeting the phosphotidylinositol 3-kinase/akt pathway. Cancer Res 2006;66:581-587.
14. Li J, Tang M-S, Liu B, Shi X, Huang C. A critical role of PI-3K/Akt/JNKs pathways in benzoapyrene diol-epoxide(BaPDE)-induced AP-1 transactivaiton in mouse epidermal CI41 cells. Oncogene 2004;23:3932-3944.
15. Kundu JK, Surh Y-J. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res 2004;555:65.
16. Young MR, Yang H-S, Colburn NH. Promising molecular targets for cancer prevention: AP-1, NF-kappaB and Pdcd4. Trends Mol Med 2003;9:36-41.
17. Tober KL, Cannon RE, Spalding JW, et al. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-rasTg.AC transgenic mice and FVB/N mice. Biochem Biophys Res Commun 1998;247:644-653.
18. Ding J, Li J, Chen J, et al. Effects of polycyclic aromatic hydrocarbons (PAHs) on vascular endothelial growth factor induction through phosphatidylinositol 3-kinase/ap-1-dependent, HIF-1{alpha}-independent pathway. J Biol Chem 2006;281:9093-9100.
19. Huang C, Li J, Costa M, et al. Hydrogen peroxide mediates activation of nuclear factor of activated T cells (NFAT) by nickel subsulfide. Cancer Res 2001;61:8051-8057.
20. Huang C, Ding M, Li J, et al. Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide. J Biol Chem 2001;276:22397-22403.
21. Li J, Huang B, Shi X, Castranova V, Vallyathan V, Huang C. Involvement of hydrogen peroxide in asbestos-induced NFAT activation. Mol Cell Biochem 2002;161:234-235.
22. Horsley V, Pavlath GK. Nfat: Ubiquitous regulator of cell differentiation and adaptation. J Cell Biol 2002;156:771-774.
23. Palanki M. Inhibitors of AP-1 and NF-kappa B mediated transcriptional activation: Therapeutic potential in autoimmune diseases and structural diversity. Curr Med Chem 2002;9:219-227.
24. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-{{kappa}}B pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-142.
25. Bode AM, Dong Z. Targeting signal transduction pathways by chemopreventive agents. Mutat Res 2004;555:33-51.
26. Keum Y-S, Jeong W-S, Tony Kong AN. Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutat Res 2004;555:191-202.
27. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001;104:487-501.
28. Szlosarek P, Balkwill F. Tumour necrosis factor α: A potential target for the therapy of solid tumours. Lancet Oncol 2003;4:565-573.
29. Bancroft CC, Chen Z, Yeh J, et al. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-κB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 2002;99:538-548.
30. McCarty MF, Liu W, Fan F, et al. Promises and pitfalls of anti-angiogenic therapy in clinical trials. Trends Mol Med 2003;9:53-58.
31. Bobrovnikova-Marjon EV, Marjon PL, Barbash O, Vander Jagt DL, Abcouwer SF. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine vailability: Role of nuclear factor-{kappa}B and activating protein-1. Cancer Res 2004;64:4858-4869.
32. Liu Z, Schwimer J, Liu D, Greenway FL, Anthony CT, Woltering EA. Black raspberry extract and fractions contain angiogenesis inhibitors. J Agric Food Chem 2005;53:3909-3915.
33. Chen Y, Law P, Loh H. Inhibition of PI3K/Akt signaling: An emerging paradigm for targeted cancer therapy. Curr Med Chem Anti Canc Agents 2005;5:575-589.
34. Lawlor MA, Alessi DR. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? Cell Sci 2001;114:2903-2910.
35. Berven LA, Crouch MF. Cellular function of p70S6K: A role in regulating cell motility. Immunol Cell Biol 2000;78:447-451.
36. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999;401:86-90.
37. Downward J. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 2004;15:177-182.
38. Nidai Ozes O, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401:82-85.